IRIS
LEGGIO, GIAN MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.511
EU - Europa 3.547
AS - Asia 3.026
SA - Sud America 549
AF - Africa 398
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 14.043
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.276
SG - Singapore 1.477
IT - Italia 1.285
RU - Federazione Russa 1.005
CN - Cina 833
BR - Brasile 471
IE - Irlanda 392
VN - Vietnam 238
UA - Ucraina 228
CI - Costa d'Avorio 215
CA - Canada 176
FR - Francia 147
KR - Corea 102
DE - Germania 101
GB - Regno Unito 78
IN - India 69
SN - Senegal 64
BD - Bangladesh 57
NG - Nigeria 55
NL - Olanda 51
SE - Svezia 50
HK - Hong Kong 39
FI - Finlandia 36
ES - Italia 32
MX - Messico 31
PL - Polonia 30
BE - Belgio 26
JP - Giappone 25
TR - Turchia 25
ZA - Sudafrica 24
ID - Indonesia 23
IQ - Iraq 22
AR - Argentina 21
CH - Svizzera 16
PK - Pakistan 16
IR - Iran 13
UZ - Uzbekistan 13
CO - Colombia 12
EC - Ecuador 12
KE - Kenya 11
LB - Libano 11
LT - Lituania 11
AT - Austria 10
BJ - Benin 10
GR - Grecia 10
JM - Giamaica 10
VE - Venezuela 10
AZ - Azerbaigian 8
SA - Arabia Saudita 8
CZ - Repubblica Ceca 7
AE - Emirati Arabi Uniti 6
DZ - Algeria 6
JO - Giordania 6
PH - Filippine 6
BG - Bulgaria 5
BO - Bolivia 5
CL - Cile 5
CR - Costa Rica 5
KZ - Kazakistan 5
PY - Paraguay 5
BA - Bosnia-Erzegovina 4
EU - Europa 4
IL - Israele 4
PE - Perù 4
SI - Slovenia 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
QA - Qatar 3
RO - Romania 3
DK - Danimarca 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MA - Marocco 2
MD - Moldavia 2
PT - Portogallo 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
ET - Etiopia 1
HU - Ungheria 1
LU - Lussemburgo 1
LV - Lettonia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
SM - San Marino 1
Totale 14.039
Salva come PNG Salva come JPEG
Città #
Santa Clara 862
Singapore 848
Dallas 836
Houston 595
Chandler 469
Moscow 432
Dublin 388
San Jose 388
Catania 340
Jacksonville 298
Ashburn 292
Chicago 280
Abidjan 215
Boardman 167
Hefei 151
Beijing 137
Lauterbourg 105
Andover 103
Cambridge 102
Los Angeles 102
Seoul 102
Lawrence 101
Toronto 98
Nanjing 88
Messina 81
New York 80
Council Bluffs 75
Civitanova Marche 72
Des Moines 68
Ho Chi Minh City 66
Dakar 64
Hanoi 50
Florence 44
Wilmington 42
Palermo 39
São Paulo 39
Hong Kong 34
Ottawa 34
Amsterdam 33
Shenyang 32
The Dalles 32
Rome 31
Hebei 30
Lagos 29
Milan 29
Columbus 28
Bremen 27
Buffalo 27
Munich 27
Saint Petersburg 27
San Mateo 27
Orem 26
Changsha 25
Jiaxing 25
Montreal 24
Tianjin 24
Warsaw 23
Brooklyn 22
Falls Church 22
Nanchang 22
Seattle 22
Dong Ket 21
Atlanta 20
Tokyo 20
Abuja 19
Rio de Janeiro 19
Denver 18
Johannesburg 18
Kraainem 16
Helsinki 15
Guangzhou 14
Poplar 14
Chennai 13
Dearborn 13
Grafing 13
Haiphong 13
Jakarta 13
Jinan 13
Washington 13
London 12
Philadelphia 12
Phoenix 12
Mexico City 11
Baghdad 10
Belo Horizonte 10
Brussels 10
Cotonou 10
Curitiba 10
Lappeenranta 10
Redwood City 10
San Francisco 10
Zhengzhou 10
Aci Catena 9
Brasília 9
Mascalucia 9
Naples 9
Ankara 8
Belpasso 8
Irvine 8
Kingston 8
Totale 9.391
Salva come PNG Salva come JPEG
Nome #
Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. 570
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 298
Current drug treatments targeting dopamine D3 receptor 244
Dopaminergic-GABAergic interplay and alcohol binge drinking 237
Blockade of dopamine D3 receptors improves hippocampal synaptic function and rescues age‐related cognitive phenotype 234
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 222
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 188
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 186
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 185
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 179
Anthocyanin Effects on Vascular and Endothelial Health: Evidence from Clinical Trials and Role of Gut Microbiota Metabolites 175
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer’s disease 173
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 172
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 165
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 165
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits 164
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 164
Neurobiological links between depression and AD: the role of TGF-β1 signaling as a new pharmacological target 164
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 159
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 152
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 150
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 148
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 147
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 145
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 142
Sex dimorphism controls dysbindin-related cognitive dysfunctions in mice and humans with the contribution of COMT 141
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 139
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 139
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 134
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 134
Epigenetic drugs for Alzheimer's disease: hopes and challenges 133
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 132
Identification of Dysregulated microRNA Networks in Schwann Cell-Like Cultures Exposed to Immune Challenge: Potential Crosstalk with the Protective VIP/PACAP Neuropeptide System 130
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 129
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 129
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 128
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 128
Retinal protection and distribution of curcumin in vitro and in vivo 127
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 127
APP expression in dopamine D3 receptor knock out mice brain during memory consolidation 126
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 125
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 123
Behavioral modifications induced by dietary cholesterol in rats 123
P2X7 receptor antagonism: implications in diabetic retinopathy 122
Dopamine D3 receptor, neurofibromin and amyloid precursor protein expression during learning 122
Long-lasting rescue of schizophrenia-relevant cognitive impairments via risperidone-loaded microPlates 121
L'uso dell'acido alfa-lipoico in neurologia 121
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 118
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE 117
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 116
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 115
Fluoxetine prevents Aβ1-42-induced toxicity via a paracrine signaling mediated by transforming-growth-factor-β1 114
High Glucose Exposure Impairs L-Cell Differentiation in Intestinal Organoids: Molecular Mechanisms and Clinical Implications 113
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 112
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 112
Anthocyanin metabolites from gut microbiota and cognitive health 110
Dopamine D3 receptor knockout mice exhibit increased hippocampal cAMP response element binding protein (CREB) following acquisition of passive avoidance memory 107
Cortico-cortical transfer of socially derived information gates emotion recognition 106
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 106
Pharmacological and genetic evidence of dopamine receptor 3-mediated vasoconstriction in isolated mouse aorta 102
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 102
Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate 102
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 102
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 100
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 100
Polyphenols and neuroprotection: Therapeutic implications for cognitive decline 100
Prenatal stress induces a depressive-like phenotype in adolescent rats: The key role of TGF-β1 pathway 96
Hippocampal neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice following passive avoidance conditioning. 96
Dopamine-3 receptor modulates intraocular pressure: implications for glaucoma 95
The Role of Dopamine D3 Receptors, Dysbindin, and Their Functional Interaction in the Expression of Key Genes for Neuroplasticity and Neuroinflammation in the Mouse Brain 94
Acute stress alters recognition memory and AMPA/NMDA receptor subunits in a sex-dependent manner 93
New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease-modifying drugs 93
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 93
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: Focus on brexpiprazole and pimavanserin 92
Dysbindin-1A modulation of astrocytic dopamine and basal ganglia dependent behaviors relevant to schizophrenia 90
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 90
Tackling dipeptidyl peptidase IV in neurological disorders 89
Ultra-Processed Food Consumption and Depressive Symptoms in a Mediterranean Cohort 86
Influence of inulin on plasma isoflavone concentrations in healthy postmenopausal women 86
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 86
Oral Echinacea purpurea extract in low-grade, steroid-dependent, autoimmune idiopathic uveitis: a pilot study 86
Enhanced expression of PACAP and of its high affinity receptor (PAC1) in the hippocampus and cerebral cortex of dopamine D3 knockout mice. 86
Effects of citalopram combined with memantine in forced swimming test in rats 86
Dopamine D3 receptor modulates tissue type plasminogen activator (tPA) activity in mouse brain 85
Physiological and therapeutic relevance of constitutive activity at 5HT2C receptors 84
Clinical pharmacology of novel anti-Alzheimer disease modifying medications. 82
Flavopiridol, an inhibitor of cyclin-dependent kinase 4, reverses cognitive deficits induced by β-amyloid peptide 1–42 82
New drugs in psychiatry: Focus on new pharmacological targets 82
Effects Of COOH-terminal tripeptide alpha-MSH (11-13) on corneal epithelial wound healing:role of nitric oxide 81
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 80
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 80
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 79
In vivo evidence that constitutive activity of serotonin2C receptors in the medial prefrontal cortex participates in the control of dopamine release in the rat nucleus accumbens: differential effects of inverse agonist versus antagonist 77
Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning. 77
Imputed expression of schizophrenia-associated genes and cognitive measures in patients with schizophrenia 76
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 75
Neurofibromin and amyloid precursor protein expression in dopamine d3 receptor knock-out mice brains 75
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 75
Parkin expression profile in dopamine d3 receptor knock-out mice brains 75
Serotonin(2C) receptors in the medial prefrontal cortex facilitate cocaine-induced dopamine release in the rat nucleus accumbens 74
Totale 12.691
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022851 101 111 15 18 134 45 113 27 63 7 33 184
2022/20231.422 115 92 18 163 143 214 17 263 325 6 41 25
2023/2024671 44 80 42 33 24 165 10 54 3 21 117 78
2024/20253.114 57 436 154 242 694 432 115 154 221 219 212 178
2025/20265.970 346 292 976 425 834 1.161 651 116 356 313 354 146
2026/202758 58 0 0 0 0 0 0 0 0 0 0 0
Totale 14.304